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More than a decade has passed since the release of the Drosophila melanogaster genome and
the  ﬁrst predictions of fruit ﬂy regulatory peptides (neuropeptides and peptide hormones).
Since then, mass spectrometry-based methods have fuelled the chemical characterisation
of  regulatory peptides, from 7 Drosophila peptides in the pre-genomic area to more  than 60
today. We review the development of fruit ﬂy peptidomics, and present a comprehensive
list  of the regulatory peptides that have been chemically characterised until today. We also
summarise the knowledge on peptide processing in Drosophila, which has strongly proﬁted
from a combination of MS-based techniques and the genetic tools available for the fruit
ﬂy.  This combination has a very high potential to study the functional biology of peptide
signalling on all levels, especially with the ongoing developments in quantitative MS inLC–MS
Direct mass spectrometric peptide
proﬁling
Quantitative mass spectrometry
Proprotein processing
Drosophila.
©  2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). 
Due to its genetic amenability, Drosophila is today a
Open access under CC BY-NC-SA license.1.  Introduction
Regulatory peptides have important functions: neuropeptides
act as neuromodulators within the nervous system, and
peptide hormones are released from neurohemal sites or
endocrine cells into the circulation to regulate body functions.
As the most diverse group of molecules involved in cell-to-
cell communication, regulatory peptides are involved in the
regulation of many  physiological processes ranging from the
∗ Corresponding author. Tel.: +49 931 31 85380; fax: +49 931 31 84452.
E-mail addresses: dennis.pauls@uni-wuerzburg.de (D. Pauls), jiangt
wencke.reiher@uni-wuerzburg.de (W.  Reiher), jens.vanselow@virchow.
andreas.schlosser@virchow.uni-wuerzburg.de (A. Schlosser), kahnt@m
christian.wegener@uni-wuerzburg.de (C. Wegener).
http://dx.doi.org/10.1016/j.euprot.2014.02.007
2212-9685 © 2014 The Authors. Published by Elsevier B.V. on behalf ofcontrol of diuresis to the orchestration of complex behaviours.
As peptides secreted by the regulated secretory pathway, they
are packaged into dense-core vesicles within which they are
processed from larger precursor molecules (prepropeptides)
by a speciﬁc set of enzymes.ian.chen@uni-wuerzburg.de (J. Chen),
uni-wuerzburg.de (J.T. Vanselow),
pi-marburg.mpg.de (J. Kahnt),
favourite organism to study the physiological functions of
regulatory peptides, with strongly increasing numbers of
publications in the recent years especially on the role of
 European Proteomics Association (EuPA). Open access under CC BY-NC-SA license.
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europeptides in the control of feeding and metabolism,
geing, learning and memory,  circadian clock and ecdysis
ehaviour (see [1]). Besides the advanced genetic tools avail-
ble for the fruit ﬂy, the advent and still ongoing improvement
f mass spectrometric methods combined with the minia-
urisation of HPLC techniques represent an important corner
tone of what is currently a highly exciting ﬁeld of fruit
y research. As predicted more  than 10 years ago [2], these
echniques allowed to chemically characterise the regulatory
eptides in an efﬁcient and straight-forward manner, thus
roviding the fundamental knowledge of “which peptides are
resent” (or in more  elegant terms “the peptidome”) upon
hich functional studies are based. The Drosophila peptidome
as predicted in silico [3–5] already soon after the release of the
rosophila genome [6] and was later substantially expanded
nd reﬁned [7]. In retrospect, these predictions have in most
ut not all cases been correct (see below), showing that pep-
ide processing and posttranslational modiﬁcation is not fully
redictable. Thus, peptidomics was and still is the only way to
dentify which regulatory peptides are existing and thus could
e employed as communication signals by the fruit ﬂy.
In this review, we will brieﬂy summarise the peptidomic
tudies performed in Drosophila with focus on regulatory
eptides (for information on the different immune-related
eptides see [8–10]). We  compile a list of the hitherto chem-
cally identiﬁed fruit ﬂy regulatory peptides, and review the
enetic and peptidomic studies of peptide processing in
he fruit ﬂy. At the end, we  give an outlook on emerg-
ng quantitative peptidomic methods in Drosophila that will
llow to address regulatory peptide dynamics under differ-
nt physiological regimes or after transgenic or mutational
anipulations.
.  Peptidomics  in  Drosophila
hile Drosophila as a genetic model organism has clear exper-
mental advantages also in the study of peptide processing, its
mall size had for a long time been a substantial challenge for
he biochemical analysis of neuropeptides. Up to the year 2000,
nly 7 neuropeptides had been biochemically characterised
n Drosophila [11–14], while at the same time several dozens
f peptides each had been sequenced by Edman degradation
rom larger insect species such as locusts and cockroaches
15–17]. Yet, with the sequencing of the fruit ﬂy genome [6]
nd the advent of powerful peptidomic techniques such as
C/MS–MS [18] and direct peptide proﬁling [19] it eventually
ecame possible to chemically characterise the Drosophila pep-
idome. Supplementary Table 1 lists the sequences and tissue
istribution of all peptides that have so far been chemically
haracterised in Drosophila.
.1.  Peptide  characterisation  by  LC–MS
he history of Drosophila peptidomics starts with the pioneer-
ng work of Baggerman and colleagues in Drosophila larvae [20],
sing capHPLC/ESI-Q-TOF MS/MS  to identify 28 neuropeptides
rom an extract of central nervous systems (CNS) prepared
rom 50 larvae (see Supplementary Table 1). This could later
e improved by switching from a one- to a two-dimensional ( 2 0 1 4 ) 114–127 115
capHPLC-separation, yielding 38 peptides from an extract of
50 larval CNS [21] (see Supplementary Table 1). Using different
combinations of LC/MS–MS methods to analyse the peptidome
from adult brain extracts, Yew et al. [22] could characterise 42
neuropeptides by MALDI-FTMS and fully sequence 26 peptides
by ESI-QTOF MS/MS (see Supplementary Table 1). Intriguingly,
some of the peptides found in the brain were later on also
identiﬁed in extracts of the midgut, the part of the fruit ﬂy
digestive tract that contains enteroendocrine cells. In fact,
all 23 enteroendocrine peptides identiﬁed by ofﬂine capHPLC
combined with MALDI-TOF MS/MS [23] can be classiﬁed as
brain–gut peptides (see Supplementary table 1). Besides these
studies with a peptidomic scope, LC/MS alone [24] or in combi-
nation with reverse pharmacology [25] or radioimmuno-assay
[26] was also employed to speciﬁcally identify and characterise
single peptides.
2.2.  Peptide  characterisation  by  direct  peptide  proﬁling
Along with LC–MS, direct peptide proﬁling has been success-
fully used to identify fruit ﬂy peptides. In this method, ﬂy
tissues such as a neurohemal organ or part of the brain is
dissected and transferred to a MALDI target plate and left to
dry. After addition of an appropriate matrix solution, peptides
are extracted and can be directly analysed by MALDI-MS (see
[19]). While not working for all tissues, a major advantage of
direct proﬁling is the circumvention of the unavoidable pep-
tide loss during LC and adsorption to plastic ware.  In addition
and in contrast to conventional extraction methods leading
to cell disruption, the on-plate extraction in direct proﬁling
apparently leads to a highly selective extraction of regulatory
peptides but not intracellular peptides. Direct peptide proﬁling
thus allows peptide identiﬁcation from single tissues of sin-
gle ﬂies. Measuring neurohemal organ and brain tissue, this
technique allowed the ﬁrst characterisation of the neuropep-
tidome of adult ﬂies and revealed 32 different neuropeptides
[27] (see Supplementary Table 1). The same approach was
later used for larval neurohemal organs and the endocrine
Inka/epitracheal cells, detecting 23 different peptides [28] (see
Supplementary Table 1). The ability of direct peptide proﬁl-
ing to reveal the ﬁner tissue distribution of peptides led to
the discovery of a differential processing of the CAPA neuro-
peptides between neurohemal organs of the brain and ventral
ganglion [27,28] as described below. Direct peptide proﬁling
also allowed the chemical identiﬁcation of not less than 27
neuropeptides within the antennal lobes of adult fruit ﬂies
[29]. Like LC–MS, direct peptide proﬁling was also employed to
speciﬁcally characterise and identify single peptides [30–33]
(see Supplementary Table 1).
2.3.  Peptide  characterisation  in  single  cells  or  enriched
neuron  populations
While the high sensitivity of mass spectrometers enables
direct peptide proﬁling even from single cells (e.g. [34–37]), it
is more  an art than a technology to isolate single ﬂy neurons
suited for MS analysis, as even small neuropeptide contam-
inations from membrane remains of passing neurites may
result in detectable mass peaks and conventional enzyme
digestion for cell separation can lead to a loss of peptide
 m i c s116  e u  p a o p e n p r o t e o
signals [38]. On the other hand, peptidergic ﬂy neurons can be
selectively labelled by green ﬂuorescent protein (GFP) using
the GAL4-UAS binary expression system [39], as many  spe-
ciﬁc peptide GAL4-lines are available. Using GAL4-UAS-driven
GFP expression, Neupert and colleagues [40] could manually
isolate PDF- or HUGIN-PK-expressing neurons and analyse
their peptide contents. Taking another approach, Yew and col-
leagues [22] used the speciﬁc peptidergic c929-GAL4 line or a
Dopa-decarboxylase-GAL4 (Ddc-GAL4) line to express mCD8-
GFP in around 200 peptidergic or dopaminergic/serotonergic
neurons. After enzymatic treatment, suspended cells were
enriched by immunocapture. This led to the successful iden-
tiﬁcation of neuropeptides that are contained within the
c929-GAL4 neurons or co-localised with dopamine/serotonin.
While this cell enrichment is susceptible against contami-
nations, immunocytochemistry veriﬁed the results for those
peptides tested.
2.4.  Disagreements  with  peptide  predictions  and
limitations  of  peptidomics  in  Drosophila
Since the ﬁrst peptidome predictions [3–5], prepropeptide pre-
diction and especially the prediction of peptide processing
has been improved and new bioinformatic tools and pipelines
have been developed (e.g. [7,41,42]). This improvement is
largely based on the growing genomic and peptidomic data,
which allows to bioinformatically compare a large set of
actually made peptides with the respective preproproteins
derived from the genome. Nevertheless, still today to pre-
dict a processed peptide does not necessarily infer it is really
made. In Drosophila,  e.g. HUG- has been predicted, and shown
to activate the respective pyrokinin receptor to a signiﬁcant
degree but with a considerably higher EC50 than the chemically
identiﬁable peptide paracopy from the same prepropeptide
[43–45]. The native peptide or its corresponding mass was,
however, not found in any of the peptidomic studies in con-
trast to the other peptide paracopy (HUG-PK) contained on
the propeptide. This mismatch may – at least for HUG-
– be caused by amino acid differences in propeptide areas
outside the basic cleavage sequence [46]. To give another
example: although sNPF-1 occurs in the predicted long form
with 11 amino acids [3], the shorter unpredicted form sNPF4–11
appears to be more  abundant and is identical to sNPF-212–19
which apparently does not occur in the predicted long form
(see Supplementary Table 1). This short form is however fully
compatible with the rules postulated earlier on by Veenstra
[47]. Moreover, masses corresponding to the predicted sNPF-3
and -4 [3,41] could not be detected until Yew and colleagues
[22] showed that these peptides are unexpectedly cleaved and
retain a basic Lys residue at their N-terminus. An interesting
example are also the predicted amnesiac-derived PACAP-like
peptides [48]. While amnesiac has convincingly been shown to
play an important role in learning and memory  and other pro-
cesses (e.g. [49–51]), none of the predicted peptides has so far
been found in the brain. Clearly, the failure to detect a peptide
by mass spectrometry does not prove the non-existence of a
peptide. Nor does the biochemical detection of a peptide prove
its function as a neuronal signalling molecule or a peptide
hormone, since also immune-induced peptides are produced
by the CNS and midgut. Furthermore, some peptides may 3 ( 2 0 1 4 ) 114–127
actually act intra- rather than extracellularly (see Ferro et al.,
this special issue). These examples highlight, however, the
importance and indispensability of a biochemical character-
isation as still the only way to demonstrate the presence of
bioactive peptides.
A caveat of the peptidomic approach is that peptides larger
than 6 kDa have so far been very difﬁcult to analyse by MS.
Thus, eclosion hormone, prothoracicotropic hormone (PTTH),
insulin-like peptides (DILPs) and other larger fruit ﬂy peptides
are still chemically uncharacterised. Recent advances in mass
spectrometry, i.e. top-down proteomics on instruments with
high resolving power in combination with peptide fragmen-
tation techniques such as ETD [52–54] are starting to change
this situation.
3.  Peptide  processing  in  Drosophila
Once peptidomic techniques yielded a (certainly still not com-
plete) overview of the Drosophila peptidome, it was time to
employ these techniques to tackle the so far ignored biochem-
ical level of peptide processing in the fruit ﬂy. Neuropeptides
and peptide hormones are produced from larger prepro-
proteins within the regulated secretory pathway. Like other
secreted or membrane-bound proteins, the preproproteins
carry an N-terminal signal peptide which directs them to the
lumen of the rough endoplasmic reticulum. After removal of
the signal peptide, the resulting proprotein can be modiﬁed
(e.g. glycosilated) and is then exported to the trans-Golgi-
network and ﬁnally packaged within dense-core vesicles and
transported to release or storage sites. Within the trans-
Golgi and the dense-core vesicles, the bioactive peptides are
processed from the proprotein by a set of speciﬁc enzymes,
including furins, convertases, carboxypeptidases and amidat-
ing enzymes (Fig. 1, see [55] for more  details). The different
processing steps and the responsible enzymes have largely
been worked out in the 1980s and 1990s in mammalian model
species and cell cultures, often using preproinsulin as a sub-
strate [56]. This focus has not at least been driven by the role of
processing enzymes in obesity, cancer and other pathologies
as well as viral infections (e.g. [57–60]).
So, what then is the signiﬁcance of studying peptide
processing and proprotein processing enzymes in Drosophila?
A medically relevant future direction in the protein processing
ﬁeld is to unravel how processing enzymes, especially con-
vertases, are regulated in disease state [61]. The regulation
of peptide processing may also be an important yet unap-
preciated factor within the (neuro)endocrinological control
of behaviour and physiology, since processing enzymes are
in principal well positioned to inﬂuence peptide production
in a general way affecting all tissues in an organism. This
ﬁeld is basically unexplored, yet recent evidence suggests that
convertase and carboxypeptidase activity can be regulated by
biogenic amines in cultured chromafﬁn cells [62]. Convertase
gene expression has also been shown to be regulated by pho-
toperiod in the Siberian hamster [63] and by the molecular
circadian clock work in Drosophila [64]. The functional signiﬁ-
cance of these ﬁndings are unclear, but Drosophila lends itself
as an excellent model to study the cellular and systemic mech-
anisms and functions of processing regulation: (a) Drosophila
e u  p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 114–127 117
Fig. 1 – Current model of peptide processing in the regulated secretory pathway of Drosophila. During translation, the
prepropeptide containing a signal peptide (SP, grey), two peptide-containing stretches (P1, P2 in red and orange) and spacer
regions (in blue) is translocated into the endoplasmic reticulum and the signal peptide is removed. The resulting propeptide
is then transported to the Golgi apparatus where peptide processing by furins (and perhaps some early PC activity) may
already start. Dense-core vesicles containing propeptides and processing enzymes bud from the trans-Golgi. Within the
dense-core vesicles, (further) processing takes place by the indicated enzymes. First, the prohormone convertase AMON
cleaves the propeptide C-terminally of mono- or dibasic cleavage sites [47]. Then, the carboxypeptidase D SILVER removes
the C-terminal cleavage sequence. In case of the presence of a C-terminal Gly residue after carboxypeptidase action (P2), Gly
is cleaved at the C-atom by the amidating enzymes PAL1 or PAL2 plus PHM, resulting in a C-terminal amidation. The role
of the chaperone 7B2 in activating/modulating AMON is not fully explored yet. Further peptide modiﬁcation may occur (e.g.
forming of an N-terminal pyroGlu, sulfatation) but is not indicated. The resulting bioactive peptides are then released by
Ca2+-mediated vesicle exocytosis. (For interpretation of the references to colour in text, the reader is referred to the web
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as an unrivalled genetic toolbox; (b) the Drosophila genome
nly contains one proprotein convertase gene (amon) and only
ne relevant carboxypeptidase gene (silver),  eliminating func-
ional redundancy which complicates genetic interference
ith peptide processing in mammals, and (c) biochemical
nalyses in the small ﬂy have become possible with the advent
f highly sensitive and sophisticated mass spectrometers and
he miniaturisation of chromatographic ﬂow rates to the l
capLC) or nl (nanoLC) range (see 2.1).
After release into the extracellular space, peptides are
urther processed and degraded by peptidases such as
eprilysins. This has recently been reviewed for Drosophila and
ther insects [65] and is not discussed here.
.1.  Genetics  and  structure  of  Drosophila  processing
nzymes
he Drosophila genome contains several genes predicted to
ncode enzymes potentially involved in neuropeptide biosyn-
hesis (Table 1, [5]): three subtilisin-like serine endoproteases,
wo carboxypeptidases, three amidating enzymes, and one
rolyl-endoprotease (CG5355). The functions and genetics of
CPM and prolyl-endoprotease are uninvestigated, in contrast
o the remaining genes which have been well characterised
ven before the Drosophila genome became accessible. In addi-
ion, there are six angiotensin-converting enzyme (ACE)-likeenzymes (ACER, ANCE, ANCE2-5). Of the ACE-like enzymes,
only ACER and ANCE appear to be active enzymes [66] and are
involved in peptide degradation or modiﬁcation after release
rather than in prohormone processing (see [65]) These ACE-
like enzymes are therefore not reviewed here.
Cathepsins provide an alternative propeptide processing
pathway in mammals, where they can act as endopeptidases
and aminopeptidases inside secretory vesicles [67,68]. These
cysteine proteases participate in lysosomal protein degrada-
tion and other processes, yet it is unknown whether any of the
Drosophila cathepsins is involved in the processing of regula-
tory peptides.
3.2.  Subtilisin-like  endoproteases:furins
The characterisation of prohormone processing genes started
1991 by the work of Roebroek and colleagues [69], who used
a phage library of Drosophila genomic DNA to screen for
human furin sequences. This approach revealed dfur1 and
dfur2 [69,70]. dfur1 is a 7.3 kb gene of 13 exons which, by
alternative splicing, gives rise to three furin-like proteins dFU-
RIN1 (892 aa), dFURIN1-CRR (1101 aa) and dFURIN1-X (1269 aa,
[71]). All three dFURIN1 are identical up to amino acid residue
775, but differ in their C-terminal sequence. The common
part of all three proteins includes a putative transmem-
brane domain, a pro domain followed by a subtilisin-like
118  e u  p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 114–127
Table 1 – Enzymes encoded in the Drosophila genome with relation to prepropeptide/preproprotein processing.
Protein symbol Enzyme Protein family Gene
AMON (dPC2) Prohormone convertase 2 Peptidase S8/proprotein
convertase
amontillado
dFUR1 dFURIN1 Peptidase S8/furins furin 1
dFUR2 dFURIN2 Peptidase S8/furins furin 2
CG5355 Prolyl endopeptidase Peptidase S9 CG5355
dCPD (SVR) Carboxypeptidase D Peptidase
M14/carboxypeptidase
silver
dCPM Carboxypeptidase M Peptidase
M14/carboxypeptidase
CG4678
PAL1 Peptidyl--hydroxyglycine--
amidating lyase
1
Peptidyl-alpha-hydroxyglycine
alpha-amidating lyase
Peptidyl-˛-hydroxyglycine-˛-
amidating lyase
1
PAL 2 Peptidyl--hydroxyglycine--
amidating lyase
2
Peptidyl-alpha-hydroxyglycine
alpha-amidating lyase
Peptidyl-˛-hydroxyglycine-˛-
amidating lyase
2
PHM Peptidylglycine--hydroxylating Copper  type II
asc
mo
Peptidylglycine-˛-hydroxylating
monooxygenase
catalytic domain and the middle domain, and is also found
in dFURIN2 (1680 aa). dFURIN1-X has a unique domain of
377 amino acid residues encoded by exon 10, located after
amino acid residue 775 and without special structural fea-
ture. dFURIN-CRR consists of a cysteine-rich region, divided
into two subdomains, beyond amino acid residue 856. dFU-
RIN1 and dFURIN2 lack an N-terminal signal peptide but
contain an additional potential transmembrane domain at
the C-terminal end. In contrast, dFURIN1-X and dFURIN1-
CRR as well as the mammalian FURINs only contain one
transmembrane domain in the N-terminal part. Similar to
dFURIN1-CRR, dFURIN2 proteins consist of a large cysteine-
rich region beyond the middle domain [70]. The consensus
cleavage site of mammalian furins is R-X-K/R-R [72,73] which
can at least in vitro also be cleaved by proprotein conver-
tases [73]. All dFURINS display a cleavage speciﬁcity similar to
that of mammalian FURINs [74,75], and both ﬂy and human
furins have been shown to also cleave at dibasic RR or KR
and monobasic R sites when heterologously expressed in cell
culture along with different mammalian proproteins [75]. In
this assay, the cleavage speciﬁcity towards mono- and dibasic
cleavage sites appeared to be similar to mammalian PC1 but
differed to mammalian PC2 [75].
Since PCs show a redundancy of substrate cleavage speci-
ﬁcity in vitro with speciﬁc substrates in vivo, the cleavage
of precursors very likely depends on structural properties
of the substrate and amino acids surrounding recognition
sites and the differential subcellular distribution of subtilisin-
like endoproteases within the secretory pathway [76] (see
Fig. 1). This opens the possibility that dFURINS are involved
in the processing of regulatory peptides in Drosophila,  and
dFURIN1 is co-expressed with dPC2 AMONTILLADO (AMON,
see 3.3) in a few but not all peptidergic neurons: the
FMRFamide-like peptide-expressing Tv neurons and other
putatively peptidergic ap-let neurons [77,78]. The functional
importance of dFURINS in the biosynthesis of regulatory pep-
tides remains however unclear for Drosophila,  especially since
furins are commonly regarded as ubiquitous house-keeping
genes involved in the production of secreted proteins [72].
This is supported by the ﬁnding that a dFurin1 homologorbate-dependent
nooxygenase
monooxygenase
of the mosquito Aedes aegypti is involved in the processing
of the major yolk protein vitellogenin [79]. Furthermore,
FMRFamide-like immunoreactivity in the Tv neurons is com-
pletely abolished in amon mutants, suggesting that dFURIN1
is not involved in FMRFamide-like peptide processing [33].
Unlike in mammals, dFURINS appear also not to be required
for the maturation of d7B2, a chaperone important for func-
tional activation of dPC2 [80] (see 3.3). In contrast, the role of
dFURINS in processing bone morphogenetic protein signals
(Glass bottom boat, Screw) is well investigated [81–83].
3.3.  Subtilisin-like  endoproteases:proprotein
convertases
The gene encoding Drosophila prohormone convertase 2
AMONTILLADO (AMON) is composed of 12 exons with around
16 kb of genomic sequence resulting in a 97 kDa AMON  pro-
tein with 654 amino acid residues [84]. AMON shows a high
66% overall sequence identity to its human homolog PC2, with
75% identity within the catalytic domain [84,85]. In contrast,
the sequence identity of the AMON catalytic domain to dFU-
RINs is only about 50% [84]. AMON contains a signal sequence
or pre-domain, a pro-domain followed by a subtilisin-like cat-
alytic domain and the typical P-domain. The C-terminal part
consists of a short extension beyond the P-domain and no
transmembrane domain. Essential for enzymatic activity is
the active site formed by a catalytic triad (Asp, His, Ser) and
Asp at the catalytically important oxyanion hole [84]. Dur-
ing enzyme maturation, dPC2 autocatalytically activates itself,
with the release of catalytically active enzyme fully depend-
ing on the presence of the small neuroendocrine protein 7B2
[61,80]. Unlike for the dFURINs, the cleavage speciﬁcity of dPC2
AMON has not been investigated in detail. Inferred from the
reduction of peptide levels in amon mutants (see 3.6) it seems
that dPC2 shows a broader cleavage speciﬁcity for both mono
(R)- and dibasic (RR, KR, RK, KK) sites. This would be concurrent
with the situation in vertebrates [61].
The localisation of amon-expressing cells has been stud-
ied by in situ hybridisation [23,84,86], immunostainings [78,87]
and promotor-driven GAL4 expression [33,87]. AMON is
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idely expressed in what appears to be largely or exclu-
ively peptidergic cells. amon mRNA  expression peaks at late
mbryogenesis [84], and appears to be low during the lar-
al and adult stage. This may explain the large differences
n labelled cell numbers between stages and between meth-
ds, and prevents reliable cell counts. It is however clear that
MON is localised to the enteroendocrine cells in both larvae
nd adults [23,87], in the endocrine AKH cells [86] as well as
he secretory peptidergic neurons innervating the neurohe-
al  organs (corpora cardiaca, perisympathetic neurons) and
xpressing CAPA peptides, HUGIN-PK, FMRFa-like peptides,
yosuppressin, sNPFs and corazonin [33,78,87].
The importance of functional AMON in the production of
ioactive neuropeptides was genetically demonstrated by an
mon deﬁciency or nonsense or missense point mutations that
ead to a lack or impairment of the catalytic centre [85]. These
utants die after hatching from the egg or latest during lar-
al ecdyses [84,85]. A similar phenotype was also visible when
ctopically overexpressing serpin4.1 in large sets of peptider-
ic neurons, suggesting that this protein is an inhibitor of
MON [88]. An inhibitory action of this serpin on subtilisin-like
ndoproteases (human furin) has been demonstrated in vitro
88,89].
.4.  Carboxypeptidases
he silver gene in Drosophila was ﬁrst cloned and characterised
y Settle and coworkers [90]. silver encodes a metallocar-
oxypeptidase D (dCPD) with three carboxypeptidase-like
omains, a transmembrane domain and a cytosolic tail region.
he domain composition of dCPD clearly identiﬁes this protein
o be a homolog of avian CPD and mammalian CPE [91]. dCPD
ccurs in long and short protein forms. A detailed approach
nalyzing Drosophila genomic and EST database sequences
s well as RT-PCR and sequencing led to the ﬁnding that
he silver gene contains eight exons [91]. The ﬁrst exon is
lternatively spliced into three forms: 1A, 1B and 1C. Exons
A and 1B are found in both long and short forms includ-
ng N-terminal regions encoding signal peptides. In contrast,
C mRNA  does not encode for an N-terminal signal peptide
nd contains a truncated part of the ﬁrst carboxypeptidase-
ike domain. The long forms of CPD contain all three CP-like
omains, short bridge regions b1 and b2 between the CP-like
omains, and a C-terminal transmembrane domain followed
y a cytosolic tail. While all CP-like domains of dCPD fold into
 carboxypeptidase-like structure [91,92], the third domain
hares only a low sequence similarity with the ﬁrst two active
omains and lacks several key residues essential for substrate
inding and enzymatic activity [91]. It is therefore predicted
o be enzymatically inactive [91]. Domain 1A lacks a metal-
inding His residue (replaced by Gln) which strongly reduces
nzymatic activity based on reduced afﬁnity to the co-factor
n2+. This catalytical inactivity of 1A is conﬁrmed by the
nability of transgenically expressed domain 1A to rescue the
ethality of a defective silver gene [93]. The 1A domain is
hus rather involved in Zn2+-independent substrate binding.
omains 1B and 2 show a comparable enzymatic activity but
ave a different pH optimum. Domain 1B is maximally active
t pH 7–8, and domain 2 between pH 5 and 6.5. These different
H optima seem to be essential for full enzymatic efﬁciency as ( 2 0 1 4 ) 114–127 119
CPD functions in the trans-Golgi network, the secretory path-
way and the reuptake pathway, i.e. different compartments
with different pH values. Both domains trim C-terminal Arg
and Lys residues after FURIN/PC cleavage, with domain 1B
preferring Arg and domain 2 Lys [93]. All active domains of
Drosophila CPD can be inhibited by different chemicals like e.g.
para-chloromercuriphenylsulfonate (with domain 1 less sensi-
tive than domain 2) while they are activated by e.g. Co2+ (with
domain 2 less sensitive than domain 1B) [91].
The importance of functional dCPD in the production
of bioactive neuropeptides was genetically demonstrated by
embryonic lethality in a number of silver mutants [90] and ﬂies
with a P-element insertion that disrupts the silver gene [94].
The function of the second carboxypeptidase encoded in
the Drosophila genome (dCPM) is uninvestigated. As its gene
expression appears to be upregulated in the nervous system
of both larval and adult ﬂies [95], it is possible that dCPM also
contributes to neuropeptide processing.
3.5.  Amidating  enzymes
Most Drosophila peptides are C-terminally amidated (see
Supplementary Table 1), a modiﬁcation that typically is
essential for bioactivity. Each of the two steps of peptide
amidation in the fruitﬂy is catalysed by an own enzyme
encoded on a separate gene [96]. This is in contrast to the
bifunctional peptidylglycine--amidating mono-oxygenase
(PAM) of vertebrates (see [97]). First, glycine-extended interme-
diate peptides obtained after PC and subsequent CPD action
are hydroxylated by a copper-containing peptidylglycine--
hydroxylating mono-oxygenase (PHM; [77,96,97]). Then, a
peptidyl--hydroxyglycine--amidating lyase (PAL) catalyses
the cleavage of the hydroxylated intermediate to yield the
ﬁnal -amidated peptide [96,97]. The dPHM gene of around
1.4 kb contains eight exons and seven introns and encodes a
protein of 365 amino acids. dPHM consists of a hydrophobic
N-terminus and a signal peptide. It shares a high sequence
similarity to the PHM domain of vertebrate PAMs includ-
ing eight cysteine residues in homologous positions and two
histidine-rich sequence clusters likely to be required for cop-
per binding. dPHM and the PHM domain of vertebrate PAM
differ in the presence of alternative splicing sites, which
appear to be absent in the Drosophila gene. Although dPHM
is separately encoded, its exon/intron structure is fairly simi-
lar to that of the dPHM domain of vertebrate PAM, indicating
a common ancestral gene.
Two genes code for dPAL proteins [98]. Both dPAL1 and
dPAL2 share four conserved cysteine residues with the PAL
domain of vertebrate PAM, forming disulﬁde bonds, and con-
tain two potential N-glycosylation sites. In addition, dPAL1 is
characterised by putative transmembrane domains close to
both its N- and C-terminal end. dPAL2 contains a typical sig-
nal sequence motif, whereas it seems to be absent in dPAL1
[98]. dPAL2 is thus secreted, while dPAL1 remains membrane-
bound, as suggested by a differential localisation within the
regulated secretory pathway and by release studies in heterol-
ogous cell culture systems [98].
The pH-optimum of dPHM that requires copper and ascor-
bate is in an acidic pH range about 5.0 similar to the activity
of vertebrate PHM [96]. In contrast, the enzymatic activity of
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dPALs is increasing with higher pH and is at max  around pH 7.0
unlike for vertebrate PAL activity [98]. This appears to coincide
with a generally higher pH in Drosophila peptidergic vesicles
compared to vertebrate vesicles [99]. Both dPHM and dPAL act
in the secretory granules. The different pH optima for these
enzymes are thus somewhat surprising. During amidation,
PHM catalyses the production of a peptidyl--hydroxyglycine
intermediate, which is then processed further to the amidated
peptide plus glyoxylate [97]. Thus, the sequential action of
PHM and PAL may correspond with or even be regulated by
a decreasing acidic pH during secretory granule maturation.
The importance of functional dPHM in the production
bioactive neuropeptides was genetically demonstrated by a P-
element insertion that disrupts the dPHM gene and causes
embryonic lethality in homozygous stocks [77,96]. This letha-
lity appears to be caused by a lack of important motifs
including one of the two dihistidine motifs for copper bind-
ing [77]. With a mosaic approach, Taghert and colleagues also
showed that peptide amidation is required for neuropeptide-
regulated behaviour [100].
3.6.  Combining  genetics  and  peptidomics  to
characterise  the  role  of  AMON  in  peptide  processing
Given the occurrence of only one canonical PC (dPC2 AMON)
and the phenotypes indicative of impaired peptide signalling
observed in amon mutants, it is not far-fetched to assume
that AMON is the major PC involved in the processing of
fruit ﬂy peptides. This hypothesis was ﬁrst tested for adipoki-
netic hormone (AKH) which is produced by endocrine cells
intrinsic to a neurohemal organ known as corpora cardiaca
(CC) [86]. amonC241Y mutant ﬂies die early during larval devel-
opment. Lethality can however be rescued by ubiquitous
ectopic expression of a hs-amon heatshock construct [84,85]. In
amonC241Y mutant L3 larvae that received one heatshock per
day, AKH and its C-terminally extended processing interme-
diate AKH-GK could be detected by direct MALDI-TOF mass
spectrometric proﬁling of CC of individual larvae similar to
genetic controls [86]. Suspension of the heatshocks for three
days however resulted in a complete loss of the detectability
of AKH and AKH intermediates. This phenotype could be res-
cued by giving a heatshock a day prior to mass spectrometric
analysis after suspending the heatshock. This provided direct
evidence that AMON is involved in the processing of native
fruit ﬂy peptides. Surprisingly, repeating this experiment for
the CC of adult ﬂies revealed that AKH and its intermediates
are still detectable in amonC241Y mutants even after several
days without heatshock. While the underlying reasons for this
are not well understood, the difference in AKH detectability
may be related to the rapid growth and hence constant need
of new AKH synthesis in larvae, while the non-growing adults
living in small glass tubes with permanent access to food
may not need high rates of AKH production as AKH release
is not triggered by extensive ﬂight or starvation. Neverthe-
less, adding a heavy, stable isotope-labelled synthetic AKH
to the MALDI matrix in direct peptide proﬁling allowed to
semiquantify native AKH levels in amonC241Y mutants by cal-
culating the intensity ratio between labelled and native AKH.
This approach showed that adult amonC241Y mutants several 3 ( 2 0 1 4 ) 114–127
days without heatshock had 16 times lower AKH levels than
controls. Also AKH-GK was strongly reduced [86].
The semiquantitative direct peptide proﬁling approach
(with heavy stable-isotope labelled synthetic AKH, HUGIN-PK
and myosuppressin added to the tissue along with the matrix)
allowed to analyse the levels of other neuropeptide hormones
stored in the CC [33]. Like AKH, all the neuropeptide hor-
mones detectable in the CC of controls were undetectable in
amonC241Y mutant larvae 3 days after last heatshock. In adult
CC, these neuropeptide hormones could be detected in a sub-
stantial fraction of amonC241Y mutants several days after last
heatshock, albeit at strongly reduced levels [33]. In contrast
to neurohemal organs such as the CC, more  complex tissues
such as the brain or gut cannot be analysed by direct pep-
tide proﬁling. Pooled CNS and midgut extracts (the midgut
houses all enteroendocrine cells in the ﬂy) were thus analysed
by LC/MS–MS to investigate the role of AMON in processing
enteroendocrine and interneuronal peptides. In amonC241Y lar-
vae and adults several days after last heatshock, the detection
rate for most enteroendocrine peptides dropped to zero or
was very much reduced compared to controls. In adults, how-
ever, 3 out of 24 enteroendocrine peptides were detected at
the same rate in amonC241Y mutant as in controls [23]. In the
CNS, the peptide detection rate did not differ signiﬁcantly for
most peptides between amonC241Y mutant and controls (Pauls,
Reiher, Wegener, unpublished data). The results from semi-
quantitative peptide proﬁling in the CC suggest, however, that
the CNS peptides detectable in amonC241Y mutants may occur
– albeit detectable – at much lower concentration than in
controls.
These results demonstrated on the biochemical level that
AMON is a key enzyme in the processing of fruit ﬂy peptides.
It is however not entirely clear why peptides are still – albeit
at low level – detectable in adult amon-deﬁcient ﬂies. Several
reasons may account for this ﬁnding. Probably some other
subtilisin-like endoproteases (e.g. the furins) secure a base-
line production of peptides even in the absence of AMON.
This would be somewhat similar to the situation in mam-
mals, where redundancy between different PCs has been
demonstrated (e.g. [101]). It is also possible that the amonC241Y
mutation represents a hypomorph, resulting in a PC with
strongly reduced yet residual processing activity. This is, how-
ever, less likely since similar results have been obtained by
direct peptide proﬁling of adult CCs in amonQ178st mutants
(Wegener, unpublished) that are expected to produce a trun-
cated PC2 without the catalytic sites [85]. Nevertheless, several
cases are known in Drosophila where despite a stop codon or
a nonsense mutation genes have been fully translated albeit
at a lower rate [102,103]. The least exciting hypothesis is
that of a background expression of the hs-rescue transgene
even at low temperature, which is known from hs-phm con-
structs [77]. More research will be needed to address these
hypotheses.
3.7.  Combining  genetics  and  peptidomics  to
characterise  the  role  of  SILVER  in  peptide  processingSince homozygous loss of SILVER = dCPD function is lethal, and
rescue lines have so far not been produced, the general rel-
evance of dCPD for peptide processing has not been tested
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y peptidomics. Processing intermediates resulting from PC
leavage and still carrying the C-terminal mono- or dibasic
leavage signal have not been found in peptidomic studies
f insects, with exception of AKH using MALDI-TOF MS  (e.g.
22,27,28,104–106]). This suggests that the C-terminal removal
f the basic cleavage signal usually occurs fast and is not
 rate limiting step during peptide processing. In Drosophila
nd other insects, AKH is usually not detected as [M+H]+
dduct, but as [M+Na]+ or [M+K]+ adducts in MALDI-TOF MS.
n contrast, the AKH processing intermediates containing a C-
erminal basic cleavage signal are easily protonated and occur
redominantly as [M+H]+ adducts. This chemical peculiarity of
KH likely is the reason why the presumably low-abundance
rocessing intermediates can be detected for AKH, but not for
ther peptides. In Drosophila,  both AKH processing intermedi-
tes (AKH-GK and AKH-GKR) are detectable by MALDI-TOF MS
33,93], and this fortuitous ﬁnding was used to test for cleav-
ge speciﬁcity of the different dCPD domains. Different silver
onstructs corresponding to different endogenous CPD forms
roduced by alternative splicing were speciﬁcally expressed
n silver-expressing cells in a mutant background or in AKH
ells in a wildtype background. Then, the level of AKH, AKH-
K, and AKH-GKR was quantiﬁed by semiquantitative direct
eptide proﬁling. All transgenic CPD lines showed a large and
igniﬁcant reduction of AKH-GK compared to controls [93].
he results also revealed that CP domain 1 of dCPD more
eadily removes R, while CP domain 2 more  readily removes
, though both domains can act redundantly. This led to the
uggestion that CP domain 1 acts earlier and CP domain 2
cts later (at lower pH) in the maturation of secretory vesicles
93].
These results provided the so far only biochemical evidence
hat dCPD is involved in processing endogenous Drosophila
eptides. Using a similar genetic rescue as performed for dPC2
see above) would be one way to test whether dCPD is the sole
nzyme responsible for C-terminal trimming during peptide
rocessing.
.8.  Combining  genetics  and  peptidomics  to
haracterise  the  role  of  amidating  enzymes  in  peptide
rocessing
hile there is as yet no direct peptidomic data available on the
ffect of mutations in the amidating enzymes PHM and PAL,
eptide amidation is strongly compromised in ﬂies with cell-
peciﬁc RNAi-mediated downregulation of the P-type ATPase
opper transporter ATP7 [107]. PHM is one of the few enzymes
hat use copper as a cofactor, with an optimal copper con-
entration for isolated Drosophila PHM between 0.5 and 2 M
96]. During the ascorbate-dependent monoxygenase reaction,
he two spatially separated coppers alternate between a Cu(I)
nd Cu(II) state (see [97]). ATP7 transporters are regulators of
ntracellular copper homeostasis and typically located in the
embrane of the trans-Golgi network [108]. In the ﬂy, ATP7 is
xpressed in many  if not all peptidergic neurons as suggested
y ATP7-promotor-driven marker expression and peptide co-
mmunostaining [107]. In mammals, ATP7A delivers Cu(I) to
HM and other cuproenzymes in the lumen of the secretory
athway [109]. When the single Drosophila ATP7 was down-
egulated by cell-speciﬁc RNAi using the binary GAL4-UAS ( 2 0 1 4 ) 114–127 121
expression system in ﬂies kept on a copper-reduced diet, this
resulted in the occurrence of non-amidated glycine-extended
neuropeptides in direct peptide proﬁling of neurohemal and
nervous tissue [107]. It has to be stressed that such glycine-
extended processing intermediates have never been observed
in wildtype ﬂies, suggesting that the amidation process is
not a rate-limiting step in peptide processing. Since most
Drosophila peptides are C-terminally amidated and the ami-
dation is essential for receptor activation, sufﬁcient copper
supply may be as essential for the ﬂy as it is for humans
[110].
3.9.  Differential  processing  of  neuropeptides  in  the
fruit ﬂy  nervous  system
It has become textbook knowledge that vertebrate pre-
propeptides like pro-opiomelanocortin (POMC) or proglucagon
undergo tissue-speciﬁc processing, leading to differential pep-
tide expression between peptidergic cells expressing the same
prepropeptide gene (e.g. [111]). In contrast, the CAPA pre-
propeptide is so far the only insect prepropeptide that has
been shown to be differentially cleaved in a cell-speciﬁc man-
ner in various species incl. Drosophila [27,28,112–114] (see also
Neupert et al., 2014 – this special issue). The molecular rea-
son for this is unclear, while alternative mRNA  splicing of
the capa mRNA  can be excluded for the fruit ﬂy [115]. CAPA
processing is strongly impaired in all capa-expressing cells
in amon mutants [33]. Future research has to show whether
the differential CAPA processing is due to differences in the
processing enzyme complement (AMON plus further enzymes
such as furins [115]), or whether AMON speciﬁcity is mod-
ulated by the vesicle milieu or may be modulated by other
factors such as 7B2 [116].
4.  Outlook
As highlighted in this review, we have gained a solid knowl-
edge on the peptidomics of Drosophila,  and sophisticated
genetic and peptidomic techniques are established. What
is needed now is to take the next step and go from more
or less descriptional peptidomics to functional peptidomics,
as the fruit ﬂy offers unmatched opportunities to combine
advanced genetic tools with quantitative peptidomic tech-
niques to study peptide biology at all levels. The studies on
peptide processing reviewed above are a ﬁrst step into that
direction. Another set of experiments combined ectopic over-
expression/in vivo RNAi of a transcription factor (DIMMED)
and ectopic expression of a heterologous prepropeptide with
LC–MALDI-TOF or LC–ESI-MS/MS with an ion trap to study
DIMMED functions [117,118]. After ectopic expression of
DIMMED (similar to vertebrate MIST-1) and a designed pep-
tide precursor in non-peptidergic photoreceptors, Hamanaka
and colleagues could show the presence of processed peptide
in extracts from whole heads (including the photoreceptors)
by LC–MS, while the peptide is not processed when only
the peptide precursor alone is expressed [117]. This elegantly
demonstrated that DIMMED conveys a peptidergic secretory
phenotype onto otherwise non-peptidergic cells. This combi-
nation of sophisticated genetics and LC–MS was then later
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Fig. 2 – “Proof-of-principle” of quantitative peptidomics in Drosophila, using a spacer peptide generated during
eclosion-hormone (EH) processing. EH is a key neuropeptide orchestrating the motor behaviour that propels ﬂies out of their
puparium during eclosion. A comparison of immunoﬂuorescent staining intensities just before or after eclosion has shown
that EH is massively released during eclosion [126]. Flies were  raised on either 14N- or 15N-labelled yeast, then brains were
dissected from pharate females that were  either very close to eclosion or freshly eclosed with unexpanded wings. Ten
brains and thoracico-abdominal ganglia from each group were  pooled and peptides were extracted with 90% MeOH
containing 0.5% TFA. The pooled peptides were  analysed by nanoLC–MS/MS on an Orbitrap mass spectrometer (EASY-nLC
1000 coupled to LTQ Orbitrap Velos, Thermo). For relative precursor peptide quantitation, a peptide ratio (14N/15N) was
calculated for each identiﬁed peptide using Mascot Distiller (Matrix  Science) software. Since EH (8 kDa) is very difﬁcult to
detect by MS,  a smaller spacer peptide (expected to be generated in equimolar amounts to EH during processing) was
quantiﬁed. (A) Shows the structure of the EH prepropeptide. The signal peptide (SP, in grey) is removed during the
translational process. Then a subtilisin-like endoprotease (most likely dPC2) cleaves C-terminal of the dibasic cleavage
sequence KR (in red), which is then removed by a carboxypeptidase (most likely CPD). This generates EH (in mauve) and the
sequence LPAISHYTH, and – after further carboxypeptidase action – LPAISHYT, all peptides being released upon regulated
exocytosis. (B) Quantiﬁcation of LPAISHYTH and LPAISHYT before and after eclosion. To exclude unspeciﬁc effects of 15N,
reciprocal experiments were  carried out. The results show a 7–8 fold (LPAISHYT) and a around 3 fold (LPAISHYTH) decrease
of peptide levels, conﬁrming the EH stainings and indicating a massive release of EH during eclosion. (For interpretation of
web the references to colour in text, the reader is referred to the used to screen for target genes downstream of DIMMED
[118].version of this article.)The rather easy metabolic labelling of whole ﬂies with
heavy isotopes by feeding yeast raised on 15N medium
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119,120] provides an excellent opportunity to conduct
uantitative peptidomic studies in the fruit ﬂy, with achievable
eptide labelling efﬁciencies of >98% ([119] Chen, Vanselow,
chlosser, Wegener, unpublished). When feeding 15N-labelled
east to an experimental group (“heavy”), and normal unla-
elled yeast to controls (“light”), tissues of both groups can
e pooled, extracted and analysed by LC–MS. This excludes
ll artefacts of unequal peptide loss, extraction efﬁciency,
tc. between experimental and control groups. Fig. 2 gives an
xample of peptide quantiﬁcation using 15N. As 15N-labelled
east appears to have mild effects on the growth of ﬂies,
abelling should always follow a reciprocal design (Fig. 2). In
ombination with qPCR, quantitative LC–MS has an excellent
otential to study the activation of peptide signalling under
peciﬁc physiological or behavioural conditions such as stress,
unger or different behaviours.
Still a major quest is to develop techniques to identify and
deally also quantify peptides by LC–MS in the hemolymph of
ruitﬂies. Already a very difﬁcult task in large insects with a
arge hemolymph volume such as moths [121], all attempts
o reliably identify peptides in the fruit ﬂy hemolymph have
ailed so far. This failure is caused by the small amount of
emolymph (in the lower l range in larvae, <1 l per adult
y) and the low concentration of circulating peptide hor-
ones (expected to be in the nM range), and not the least
y the high peptide/protein complexity of hemolymph [122]
hich prevents simple peptide identiﬁcation by mass only
121]. In contrast, immune-induced peptides occur in the mM
ange and are easily mass spectrometrically identiﬁed in the
emolymph [8,10,123]. Development of a MS-based method
o analyse peptide hormones would be extremely helpful to
stablish Drosophila also as a true endocrinological model, e.g.
or the circadian control of peptide hormone secretion.
Peptidomic approaches have so far been limited to the
dentiﬁcation and quantitation of smaller peptides or to
he indirect analysis of non-bioactive peptides originating
rom prepropeptide processing as a proxy for larger peptide
ormones (see Fig. 2). With recent developments in mass spec-
rometry, i.e. high sensitive, high resolution mass analyzers
e.g. Orbitrap), combination of different fragmentation tech-
iques [124] and advanced analysis software [125], the analysis
lso of large peptide hormonesas well as low abundant peptide
odiﬁcations is now becoming technically feasible.
So, it’s exciting times for Drosophila peptidomics!
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Appendix  A.  Supplementary  data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.euprot.2014.02.007.
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